Antibiotic tested as potential new weapon against double disease
NCT ID NCT07341282
Summary
This small pilot study is testing if the antibiotic vancomycin, taken by mouth, can safely improve symptoms of active ulcerative colitis in adults who also have a liver disease called primary sclerosing cholangitis. Fourteen participants will take either the antibiotic or a placebo for four weeks to see if it helps. The main goal is to see if running this type of study is practical and safe, which will help plan larger future trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY SCLEROSING CHOLANGITIS (PSC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
McMaster Children's Hospital - Digestive Diseases Clinic
Hamilton, Ontario, L8N 3Z5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.